Christopher Bruce, MD
Colon & Rectal Surgery · Doylestown, PANPI 1487743027
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,027 of the $16,800 with a category attached, or 71.6%. Intuitive Surgical accounts for 81.7% of it on its own, with 19 other manufacturers making up the rest. Among colon & rectal surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $169.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Medtronic$2K
- THD America, Inc.$424
- W. L. Gore & Associates, Inc.$308
- Johnson & Johnson$162
- Ferring Pharmaceuticals Inc.$113
- plus $452 from 14 others
What the payments were for
- Speaking & faculty fees$2501%
- Travel & lodging$6814%
- Food & beverage$3,84323%
- Education$12,02772%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $13,720 |
| Medtronic | 43 | $1,621 |
| THD America, Inc. | 4 | $424 |
| W. L. Gore & Associates, Inc. | 7 | $308 |
| Johnson & Johnson | 2 | $162 |
| Ferring Pharmaceuticals Inc. | 1 | $113 |
| AbbVie | 4 | $79 |
| Bristol Myers Squibb | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Bayer | 2 | $38 |
| Merck | 2 | $27 |
| Celltrion USA Inc. | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Braintree Laboratories, Inc. | 1 | $21 |
| Kerecis Limited | 1 | $19 |
| Incyte Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Seagen Inc. | 1 | $14 |
| Conmed Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$13,075
- INTERSTIM$521
- DA VINCI SP$250
- GORE CARDIOFORM Septal Occluder$179
- SURGICEL NU-KNIT$127
- EVARREST$127
- VISTASEAL$127
- PROLENE$127
- Mega Soft$127
- REBYOTA$113
- APOLLOTM$108
How this compares
$16,800 in reported general payments places this provider in the 90th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 40 | $6,365 |
| Neomycin Sulfate | 27 | $151 |
| Oxycodone Hcl | 17 | $83 |
| Metronidazole | 30 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $21 | $6,36540 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Other colon & rectal surgery in Doylestown
- Robert AkbariDoylestown$3K
- Bogdan ProtyniakWilkes-Barre$429K
- John MarksWynnewood$155K
- Joshua BleierPhiladelphia$86K
- Richard FortunatoPittsburgh$80K
- Najjia MahmoudPhiladelphia$63K
- James McCormickMonroeville$55K
- Juan PoggioPhiladelphia$49K
- Christopher BuzasDanville$25K
- David ZebleyAbington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.